海外の治験の状況「多発性骨髄腫」での検索結果
110件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma
- Multiple Myeloma;Multiple Myeloma;Multiple Myeloma;Multiple Myeloma
- Austria
- 2014-03-04
Not Recruiting
- A Randomized, Open-label, Phase 3 Study of Carfilzomib vs Best Supportive Care in Subjects with Relapsed and Refractory Multiple Myeloma
- Multiple myeloma br>MedDRA version: 12.1 Level: LLT Classification code 10028228 Term: Multiple myeloma
- Austria, Belgium, Czech Republic, Germany, Greece, Hungary, Italy, Slovakia, Spain, Sweden, United Kingdom
- 2010-03-15
Recruiting
- Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe
- Multiple Myeloma
- Austria, Belgium, Czechia, France, Greece, Israel, Italy, Netherlands, Norway, Romania
- 2017-01-30
Not Recruiting
- Bevacizumab as treatment for patients with relapsed/refractory multiple myeloma - Avastin in MM
- Multiple myeloma, relapsed/refractory after at least 2 lines of prior therapy
- Austria
- 2006-01-18
Not Recruiting
- Myelomatosis therapy trial for patients of all age groups
- Multiple Myeloma br>Cancer Multiple myeloma and malignant plasma cell neoplasms
- New Zealand, South Africa, United Kingdom
- 2000-09-21
Recruiting
- Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years
- Multiple Myeloma
- Austria, Germany
- 2007-10-17
Recruiting
- Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy
- Multiple Myeloma
- Austria
- 2016-08-10
Not recruiting
- A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
- Multiple Myeloma
- Austria, Canada, Germany, Greece, Italy, Netherlands, Spain, Sweden, United States
- 2016-12-19
Not recruiting
- A Phase I/IIa Study of Human Anti-CD38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma
- Multiple Myeloma;Multiple Myeloma;Multiple Myeloma
- Austria, Germany
- 2011-07-29
Authorised
- Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
- Multiple Myeloma br>MedDRA version: 14.1 Level: PT Classification code 10028228 Term: Multiple myeloma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Canada, Czech Republic, European Union, Germany, Greece, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Malaysia, New Zealand, Portugal, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Turkey, United States
- 2012-05-11
